These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic. Khazeni N; Hutton DW; Garber AM; Owens DK Ann Intern Med; 2009 Dec; 151(12):840-53. PubMed ID: 20008760 [TBL] [Abstract][Full Text] [Related]
4. Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy. Rothberg MB; Bellantonio S; Rose DN Ann Intern Med; 2003 Sep; 139(5 Pt 1):321-9. PubMed ID: 12965940 [TBL] [Abstract][Full Text] [Related]
6. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis. Rothberg MB; Rose DN Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212 [TBL] [Abstract][Full Text] [Related]
7. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Turner D; Wailoo A; Nicholson K; Cooper N; Sutton A; Abrams K Health Technol Assess; 2003; 7(35):iii-iv, xi-xiii, 1-170. PubMed ID: 14609480 [TBL] [Abstract][Full Text] [Related]
8. Role of combination antiviral therapy in pandemic influenza and stockpiling implications. Tsiodras S; Mooney JD; Hatzakis A BMJ; 2007 Feb; 334(7588):293-4. PubMed ID: 17289732 [TBL] [Abstract][Full Text] [Related]
9. Preparing for pandemic influenza: should hospitals stockpile oseltamivir? Cinti S; Chenoweth C; Monto AS Infect Control Hosp Epidemiol; 2005 Nov; 26(11):852-4. PubMed ID: 16320980 [TBL] [Abstract][Full Text] [Related]
11. Economics of neuraminidase inhibitor stock piling for pandemic influenza, Singapore. Lee VJ; Phua KH; Chenm MI; Chow A; Ma S; Goh KT; Leo YS Emerg Infect Dis; 2006 Jan; 12(1):95-102. PubMed ID: 16494724 [TBL] [Abstract][Full Text] [Related]
12. Management of influenza symptoms in healthy adults. Rothberg MB; He S; Rose DN J Gen Intern Med; 2003 Oct; 18(10):808-15. PubMed ID: 14521643 [TBL] [Abstract][Full Text] [Related]
13. Economics of stockpiling for an influenza pandemic. Dhankhar P; Dasbach EJ; Elbasha EH Lancet Infect Dis; 2009 Aug; 9(8):459-60. PubMed ID: 19628168 [No Abstract] [Full Text] [Related]
14. Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK. Sander B; Hayden FG; Gyldmark M; Garrison LP Pharmacoeconomics; 2006; 24(4):373-86. PubMed ID: 16605283 [TBL] [Abstract][Full Text] [Related]
15. Modeling the worldwide spread of pandemic influenza: baseline case and containment interventions. Colizza V; Barrat A; Barthelemy M; Valleron AJ; Vespignani A PLoS Med; 2007 Jan; 4(1):e13. PubMed ID: 17253899 [TBL] [Abstract][Full Text] [Related]
16. Economic analysis of pandemic influenza vaccination strategies in Singapore. Lee VJ; Tok MY; Chow VT; Phua KH; Ooi EE; Tambyah PA; Chen MI PLoS One; 2009 Sep; 4(9):e7108. PubMed ID: 19771173 [TBL] [Abstract][Full Text] [Related]
17. Antiviral agents for influenza: a comparison of cost-effectiveness data. Lynd LD; Goeree R; O'Brien BJ Pharmacoeconomics; 2005; 23(11):1083-106. PubMed ID: 16277546 [TBL] [Abstract][Full Text] [Related]
18. Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic. Lugnér AK; Mylius SD; Wallinga J Health Econ; 2010 May; 19(5):518-31. PubMed ID: 19382106 [TBL] [Abstract][Full Text] [Related]
19. Economic model for emergency use authorization of intravenous peramivir. Lee BY; Tai JH; Bailey RR; McGlone SM; Wiringa AE; Zimmer SM; Smith KJ; Zimmerman RK Am J Manag Care; 2011 Jan; 17(1):e1-9. PubMed ID: 21485418 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Khazeni N; Hutton DW; Garber AM; Hupert N; Owens DK Ann Intern Med; 2009 Dec; 151(12):829-39. PubMed ID: 20008759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]